Masimo - PRESS RELEASE

Press Release results

Side by side of caretaker and patient wearing Masimo VSM next to Vanderbilt University Medical Center

Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in Nashville, Tennessee, is piloting the use of the Masimo Radius VSM™ patient-worn vital signs monitor with Masimo Patient

October 29, 2024

Side by side of Masimo HQ Irvine and Cleveland Clinic building

PRESS RELEASE

Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers

Masimo (NASDAQ: MASI) a leading global medical innovator, and Qualcomm Technologies, Inc., whose Snapdragon® branded platforms power extraordinary consumer experiences, today announced that Masimo is partnering with Qualcomm Technologies to develop a

September 14, 2024

PRESS RELEASE

Masimo Partners with Google to Develop a Reference Platform That Helps Device Manufacturers Bring High-performing Wear OS Smartwatches to Market

Masimo (NASDAQ: MASI) a leading global medical innovator, today announced a partnership with Google to develop a new reference platform for original equipment manufacturers (OEMs) building Wear OS by Google™ smartwatches. By incorporating Masimo’s br

September 13, 2024

Side by side of Saint-Denis Hospital Center and parent carrying baby wearing Masimo SafetyNet

PRESS RELEASE

Saint-Denis Hospital Center in France Implements Masimo SafetyNet® Telemonitoring to Facilitate Early Discharge of Premature Newborns from the Hospital

Masimo (NASDAQ: MASI) today announced that Saint-Denis Hospital Center is adopting the use of the Masimo SafetyNet® cloud-based telemonitoring platform as part of an experimental mobile neonatology unit aimed at facilitating earlier discharge of prem

September 9, 2024

PRESS RELEASE

Masimo Partners with March of Dimes to Help Parents with Babies in the NICU Make the Transition from Hospital to Home

Masimo (NASDAQ: MASI) a global leader in innovative monitoring technologies used in top hospitals, and March of Dimes, the leading non-profit organization fighting to improve health outcomes for all moms and babies, are launching a partnership to sup

August 27, 2024

Product lineup featuring Masimo SET products

PRESS RELEASE

Masimo SET® Pulse Oximetry: Superior Performance, Worldwide Presence, Immeasurable Impact

Masimo (NASDAQ: MASI) Signal Extraction Technology®, or SET®, pulse oximetry – industry-leading, clinically proven, and used by top hospitals everywhere – continues to overcome the limitations of conventional pulse oximetry and offers unrivaled accur

August 26, 2024

PRESS RELEASE

Masimo W1® Medical Watch Receives FDA 510(k) Clearance for Connectivity to the Masimo SafetyNet® Telemonitoring System

May help clinicians monitor cerebral oxygenation in situations in which pulse oximetry alone may not be fully indicative of the oxygen in the brain.

August 12, 2024

Side by side of nurse at workstation with Masimo SafetyNet monitoring system and a patient and wearing the Masimo MightySat pulse Oximeter

PRESS RELEASE

New Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Significantly Reduced Rates of Hospital Readmission and ED Visits for Patients Recuperating at Home After Joint Replacement Surgery

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the Journal of Orthopaedics in which Dr. Michael DeRogatis and colleagues at St. Luke’s University Health Network (SLUHN) in Pennsylvania, joined by researchers at

July 29, 2024

Side by side of person sleeping while wearing Masimo W1 and Masimo W1 product shot

PRESS RELEASE

Masimo Announces Sleep Halo™, Advanced Sleep Analysis for the Masimo W1®

Masimo (NASDAQ: MASI), today announced that the Masimo W1® Sport advanced health tracking wearable is gaining a powerful new feature: scientifically based sleep analysis with Sleep Halo™. Sleep Halo offers overnight sleep data tracking with an

July 26, 2024

PRESS RELEASE

Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches

Masimo (NASDAQ: MASI), a global leader in innovative noninvasive monitoring technologies, welcomes the Federal Circuit’s ruling to lift the temporary stay on the import ban of certain Apple Watch models.

July 19, 2024

Side by side of Masimo HQ in Irvine and the Cleveland Clinic building

PRESS RELEASE

Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care

Masimo (NASDAQ: MASI), a leading global provider of medical technology and hospital automation solutions, and Cleveland Clinic, a nonprofit academic medical center, announced today the launch of a new partnership centered around hospital-based remote

June 27, 2024

Joe Kiani at podium for mobilize recovery summit, bus with mobilize recovery ad on the side, masimo SafetyNet product and app, patient wearing Masimo Bridge behind ear

PRESS RELEASE

Masimo Joins Forces with the Mobilize Recovery 2024 Bus Tour

Masimo (NASDAQ: MASI), a leading global medical technology innovator, today announced that it is partnering with Mobilize Recovery, a nonprofit organization dedicated to ending America’s addiction and overdose crisis, by sponsoring and joining the Mo

June 5, 2024

Masimo W1 watch with smartphone displaying Masimo Health App and a caretaker with their patient wearing Masimo Radius VSM on forearm

PRESS RELEASE

Germans Trias i Pujol Hospital in Spain Launches Telehealth and Remote Patient Management Program Using Masimo W1® Medical Watches and Radius VSM™ Wearable Continuous Vital Signs Monitors

Masimo (NASDAQ: MASI) today announced that Germans Trias i Pujol, a pioneering hospital serving more than 800,000 people in north Barcelona, Spain, is launching a breakthrough telehealth and remote patient management initiative using Masimo

June 3, 2024

PRESS RELEASE

Masimo Receives Sustainability Seal of Approval from Practice Greenhealth

Masimo (NASDAQ: MASI), a leading medical technology innovator, and Practice Greenhealth, a prominent organization dedicated to advancing sustainability solutions for healthcare providers, today announced that Masimo is now a recipient of the

May 20, 2024

PRESS RELEASE

Masimo and Denon Introduce White PerL™ and PerL Pro™ Earbuds, Redefining Style and Customization in Personalized Audio

Masimo (NASDAQ: MASI), a global leader in innovative noninvasive monitoring technologies, and Denon, a pioneer in audio technology with over a century of audio expertise, proudly unveil the latest evolution of its acclaimed Denon PerL™ and Denon PerL

May 16, 2024

side by side of Stork camera, Stork app on smartphone and Stork boot next to baby wearing the Stork boot

PRESS RELEASE

Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System

Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies currently celebrating its 35th anniversary, announced FDA clearance of Stork™, a baby monitoring system that provides alarms to parents or other caregivers, for use with

May 6, 2024

PRESS RELEASE

Masimo Named One of Fast Company’s Most Innovative Companies in North America

Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, is thrilled to announce its recognition as one of Fast Company’s Most Innovative Companies in North America for 2024. This prestigious accolade is

April 16, 2024

PRESS RELEASE

Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile

Masimo (NASDAQ: MASI) today announced that its Founder and CEO, Joe Kiani, will be a featured speaker tomorrow, April 17, at the 6th Global Ministerial Summit on Patient Safety. Kiani’s speech, “Empowering Patient Safety Through AI,” will discuss how

April 16, 2024

split image of baby wearing Masimo stork and Bowers and Wilkins over the ear headphones

PRESS RELEASE

Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024

Masimo (NASDAQ: MASI) is proud to celebrate multiple wins across various categories at the prestigious iF DESIGN AWARDS 2024, showcasing its commitment to excellence in design and innovation throughout diverse industries.

March 7, 2024

PRESS RELEASE

Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth

Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and UCHealth, a nationally recognized network of hospitals, clinics, and providers based in Colorado, announced today that they are entering into a

February 20, 2024

person laying in bed wearing Masimo MightySat on finger. Next to image of Masimo Pulse Oximetry beauty shot

PRESS RELEASE

Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter

Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) direct to consumers without a prescription. All other pulse oximeter

February 13, 2024

Side by side of two hands wearing Masimo SET pulse oximetry on finger and writs

PRESS RELEASE

New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion

Masimo (NASDAQ: MASI), today announced the findings of a retrospective, peer-reviewed study published in the Journal of Clinical Monitoring and Computing in which Dr. Vikrant Sharma, along with Dr. Steven J. Barker, Dr. William C. Wilson, and

February 8, 2024

Side by side of baby wearing Masimo Stork on foot and Masimo Stork camera with smartphone app

PRESS RELEASE

Masimo Receives FDA Clearance for Stork™ Baby Monitoring System

Masimo (NASDAQ: MASI) ) a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby monitoring system, for prescription use with healthy and sick babies 0-18 months of age

December 18, 2023

Side by side of Masimo Root and operating room using Masimo Root

PRESS RELEASE

New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation

Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Anesthesia in which Dr. Yu Jeong Bang and colleagues at the Samsung Medical Center, Sungkyunkwan University School of Medicine, in Seoul, South Ko

December 11, 2023

PRESS RELEASE

Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use

Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter (OTC) and prescription use (Rx). Masimo W1 is the first FDA-cleared watch to provide continuous real-time oxygen saturation

November 17, 2023

PRESS RELEASE

GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform

GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse oximetry into GE HealthCare’s Portrait Mobile wireless and wearable patient monitoring solution. P

November 8, 2023

PRESS RELEASE

United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws

Masimo (NASDAQ: MASI) today announced that (NASDAQ: MASI) today announced that the United States International Trade Commission (USITC) has recommended a limited exclusion order for infringing Apple Watches with light-based pulse oximetry

October 26, 2023

Side by side of surgeons performing on patient and Masimo Root product shot

PRESS RELEASE

Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen

Masimo (NASDAQ: MASI) today announced that ORi™, a noninvasive, continuous parameter designed to provide additional insight into a patient’s oxygen status in the moderate hyperoxic range under supplemental oxygen, has been granted a De Novo by the FD

October 13, 2023

Side by side of LiDCO monitor and Masimo Root

PRESS RELEASE

Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring

Masimo (NASDAQ: MASI) today announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO® board-in-cable (BIC) module. The LiDCO BIC module is designed to connect to multi-patient monitoring platforms, like the Masimo Root

October 9, 2023

Our Lady of the Lake Health (Baton Rouge, Louisiana) and Masimo technologies, including Radius PPG®, Replica®, and Patient SafetyNet™ with Root®

PRESS RELEASE

Franciscan Missionaries of Our Lady Health System and Masimo Sign Multi-year, System-wide Monitoring Agreement

Masimo (NASDAQ: MASI) and Franciscan Missionaries of Our Lady Health System (FMOLHS), a 10-hospital system headquartered in Baton Rouge and serving communities throughout Louisiana and Mississippi, have signed a multi-year agreement to implement Masi

August 31, 2023

PRESS RELEASE

Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor

Masimo (NASDAQ: MASI) a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring system. Stork Vitals+, Vitals, and Camera combinations are now available for purchase

August 23, 2023

Side by side of operating room with Masimo Root and product shot of Masimo Root with PVi

PRESS RELEASE

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery

Masimo (NASDAQ: MASI) today announced the findings of a prospective, randomized study published in Perioperative Medicine in which Dr. Yu Wang and colleagues at institutions in Shenzhen,

August 21, 2023

Masimo Root® with SedLine® Brain Function Monitoring

PRESS RELEASE

New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine

Masimo (NASDAQ: MASI) today announced the findings of a study published in Frontiers in Neuroscience in which Dr. Lichy Han and colleagues at Stanford University evaluated the ability of Masimo SedLine® brain function monitoring to assess the

August 7, 2023

Masimo W1™ and Hospital La Fe, Valencia, Spain

PRESS RELEASE

Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients

Masimo (NASDAQ: MASI) today announced that Hospital La Fe in Valencia, Spain, is expanding its telehealth and telemonitoring program with the Masimo W1™ advanced health tracking watch. Masimo W1, which offers accurate, continuous measurements of key

June 22, 2023

Overdose and Addiction Crisis Roundtable Hosted by Masimo and the Clinton Foundation

PRESS RELEASE

Masimo and Clinton Foundation Host Roundtable Addressing Overdose and Addiction Crisis

Masimo (NASDAQ: MASI), and the Clinton Foundation today hosted an in-person roundtable addressing the overdose and addiction crisis. Joe Kiani, Founder and CEO of Masimo, and President Bill Clinton, 42nd President of the United States and Founder

June 21, 2023

Denon PerL™ True Wireless Earbuds with Masimo Adaptive Acoustic Technology™ (AAT™)

PRESS RELEASE

Masimo Expands Into the Personalized Hearables Market with Denon PerL™ True Wireless Earbuds, Featuring Masimo Adaptive Acoustic Technology™ (AAT™)

Masimo (NASDAQ: MASI), a leading developer of medical technology solutions and consumer health and audio devices, is expanding its premium Denon brand to introduce its latest innovation, Masimo AAT™ (Adaptive Acoustic Technology™). Denon PerL™ and

June 20, 2023

Community Health System (CHS) and Masimo

PRESS RELEASE

Community Health System Expands Use of Multiple Masimo Technologies, System-wide

Masimo (NASDAQ: MASI) and Community Health System (CHS), based in Fresno, California, today announced that CHS is adopting a variety of advanced Masimo monitoring technologies and solutions across its campuses. CHS, a large four-hospital network, pro

June 12, 2023

Lausanne University Hospital (CHUV) building and Masimo W1

PRESS RELEASE

Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment

Masimo (NASDAQ: MASI) today announced that the Department of Anesthesiology at the Lausanne University Hospital (CHUV), one of Switzerland’s premier academic institutions, has chosen to make the Masimo W1™ advanced health tracking watch a key part of

June 8, 2023

Side by side of patient wearing Masimo Radius VSM™ and product shot of Masimo Radius VSM™

PRESS RELEASE

Masimo Announces FDA 510(k) Clearance of Radius VSM™

Masimo (NASDAQ: MASI) today announced that Radius VSM™, a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance. Designed on a modular platform, Radius VSM allows clinicians to monitor a wide variety of

June 5, 2023

PRESS RELEASE

Masimo Announces Major Expansion of the HEOS® Platform

Masimo (NASDAQ: MASI) today announced the global expansion of the HEOS platform, enabling an always-on connection to the Masimo Health secure cloud for four million devices and empowering consumers with an enhanced health tracking experience. This so

May 24, 2023

PRESS RELEASE

Orange County Business Journal Names Masimo’s Micah Young CFO of the Year

Micah Young, Chief Financial Officer of Masimo (NASDAQ: MASI), has been awarded CFO of the Year by the Orange County Business Journal (OCBJ). In presenting the award, Outstanding CFO of a Public Company, at last night’s ceremony in Irvine, OCBJ

May 12, 2023

three side by sides of Cambridge University Hospitals Masimo W1 and smartphone and patient wearing Masimo W1

PRESS RELEASE

Cambridge University Hospitals Expands Virtual Care Program with Masimo W1™

Masimo (NASDAQ: MASI) today announced that Cambridge University Hospitals NHS Foundation Trust, U.K. is adopting the Masimo W1™ advanced health tracking watch for use in its telehealth and telemedicine programs. Masimo W1, which offers accurate, cont

May 8, 2023

PRESS RELEASE

Masimo Stork™ Delivers State-of-the-Art Baby Monitoring to the Home

Masimo (NASDAQ: MASI) a global leader in pulse oximetry and other innovative noninvasive monitoring technologies, today announced the launch of Stork, a revolutionary home baby monitoring system. This innovative system offers parents insights into

May 1, 2023

PRESS RELEASE

Masimo Announces FDA Clearance of the Rad-G® with Temperature

Masimo (NASDAQ: MASI) today announced that the Rad-G® with Temperature has received FDA 510(k) clearance. Rad-G with Temperature is a rugged, versatile, handheld monitor that provides clinically proven SET® pulse oximetry, respiration rate from the

April 18, 2023

Product shot of Masimo Opioid Halo and Smartphone showing Masimo SafetyNet app

PRESS RELEASE

Masimo Opioid Halo™ Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System

Masimo (NASDAQ: MASI) today announced that Masimo Opioid Halo™, an opioid overdose prevention and alert system, has been granted a De Novo by the FDA – making it the first and only FDA-cleared monitoring solution for detecting opioid-induced

April 3, 2023

PRESS RELEASE

Masimo Unveils the Future of Smart Wearables with the Pre-Sale Launch of the Freedom™ Smartwatch

Masimo (NASDAQ: MASI) a global leader in pulse oximetry and innovative noninvasive monitoring technologies, unveiled the newest addition to its wearable product line: the Masimo Freedom™ smartwatch. Developed to revolutionize the wearable technology

March 28, 2023

PRESS RELEASE

European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring

Masimo (NASDAQ: MASI) today announced that updated guidelines published by the European Society of Anaesthesiology and Intensive Care (ESAIC) highlight the value of noninvasive, continuous hemoglobin (Hb) monitoring in helping clinicians manage

March 15, 2023

PRESS RELEASE

New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospital in Beijing evaluated the ability of noninvasive, continuous Mas

March 9, 2023

PRESS RELEASE

Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives

Masimo (NASDAQ: MASI) a leading global provider of medical technology and automation solutions, and Temple Health, Philadelphia’s 979-bed academic health system, announced today that they are entering into a strategic innovation collaboration. With a

March 7, 2023

PRESS RELEASE

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondicherry, India evaluated the use of noninvasive, con

March 6, 2023

Side by side of operating room with Masimo Root and Masimo Root® with ORi™

PRESS RELEASE

New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy

Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized controlled study published in Medicine in which Dr. Jin Hee Ahn and colleagues at the Sungkyunkwan University School of Medicine in Seoul, Korea evaluated

February 21, 2023

Side by side of patient in bed wearing Masimo Centroid using a Masimo Root next to a product shot of Masimo Root and Centroid with smartphone

PRESS RELEASE

Masimo Centroid® Receives Innovative Technology Designation from Vizient

Masimo (NASDAQ: MASI) today announced that Centroid®, a wearable, wireless patient orientation and activity sensor, has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the

February 15, 2023

Three side by sides of clinician washing hands, Masimo VCAM™ with Root®, and security camera in hospital room

PRESS RELEASE

Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)

Masimo (NASDAQ: MASI) today announced the limited market release of Visual Clinical Activity Monitoring (VCAM™), a video analysis system that uses artificial intelligence to help facilitate compliance with hospital hand hygiene protocols. VCAM, which

January 30, 2023

Side by side of doctor operating on patient using Masimo Root for monitoring next to product shot of Masimo Root with SedLine and 03 Regional Oximetry cables

PRESS RELEASE

Researchers Harness the Power of Masimo Root®’s Advanced Multimodal Monitoring Capabilities to Study the Impact of Different Ventilatory Strategies on Brain Oxygenation During Thoracoscopic Surgery

Masimo (NASDAQ: MASI) today announced the findings of a prospective, single-blinded, randomized controlled study published in the Journal of Anesthesia & Intensive Care Medicine in which Dr. Mona Mohamed Mogahed and colleagues at Tanta University in

January 23, 2023

Side by side of clinicians using Masimo patient monitoring system next to patient laying in bed wearing Masimo W1 watch

PRESS RELEASE

Masimo and Philips Expand Partnership to Improve Telehealth for Patients and Clinicians Around the World with the Masimo W1™ Watch

Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG, AEX: PHIA) today announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with the Masimo W1™ advanced health tracking watch. The W1

January 18, 2023

PRESS RELEASE

ITC Judge Rules Apple Violated U.S. Trade Laws by Infringing Masimo Pulse Oximeter Patent

A United States Administrative Law Judge in Washington, D.C. ruled that Apple Inc. (Nasdaq: AAPL) violated Section 337 of the Tariff Act of 1930 as amended, by importing and selling within the United States certain Apple Watches with light-based

January 10, 2023

Side by side of clinician with their patient using a Masimo Rad-67 next to a product shot of Masimo Rad-67 with SpHb

PRESS RELEASE

New Study Evaluates the Performance of Masimo SpHb® Noninvasive Spot-Check Hemoglobin in the Emergency Department

Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the American Journal of Emergency Medicine in which Dr. Zohair Ahmed Ali Al Aseri and colleagues at King Saud University Medical City and Dar Al Uloom University

January 9, 2023

clinician at monitoring station, a clinician using the safetynet app on smartphone, product shot of Masimo Root with non invasive blood pressure

PRESS RELEASE

New Study Finds That Masimo Patient SafetyNet™ Helped Clinicians Reduce CPR Events and Rates, Improve CPR Success Rate, and Reduce Hospital Length of Stay and Mortality

Masimo(NASDAQ: MASI) today announced the findings of a before-and-after study published in PLoS ONE in which Dr. Ahmed Balshi and colleagues at King Saud Medical City in Riyadh, Saudi Arabia, evaluated the impact of implementing remote patient

January 5, 2023

PRESS RELEASE

New Prospective Study Evaluates the Accuracy of Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring During Elective Cesarean Section

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the Egyptian Journal of Anesthesia in which Dr. Mohamed Ibrahim Beleta and colleagues at Cairo University evaluated the accuracy of noninvasive, continuous

January 3, 2023

NEWS & MEDIA

Press Release

Recent results

Year

Press Release results